Home > Research > Publications & Outputs > Identification of challenges to the availabilit...

Electronic data

  • LingeDahl ATOME 6Country-workshop draft revision 14 07 2015_final

    Rights statement: Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/jpm.2015.0051

    Accepted author manuscript, 204 KB, PDF document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

View graph of relations

Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops. / Linge-Dahl, Lisa; Vranken, Marjolein J. M.; Jünger, Saskia et al.
In: Journal of Palliative Medicine, Vol. 18, No. 12, 12.2015, p. 1033-1039.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Linge-Dahl, L, Vranken, MJM, Jünger, S, North, K, Scholten, W, Payne, SA & Radbruch, L 2015, 'Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops', Journal of Palliative Medicine, vol. 18, no. 12, pp. 1033-1039. https://doi.org/10.1089/jpm.2015.0051

APA

Linge-Dahl, L., Vranken, M. J. M., Jünger, S., North, K., Scholten, W., Payne, S. A., & Radbruch, L. (2015). Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops. Journal of Palliative Medicine, 18(12), 1033-1039. https://doi.org/10.1089/jpm.2015.0051

Vancouver

Linge-Dahl L, Vranken MJM, Jünger S, North K, Scholten W, Payne SA et al. Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops. Journal of Palliative Medicine. 2015 Dec;18(12):1033-1039. Epub 2015 Oct 20. doi: 10.1089/jpm.2015.0051

Author

Linge-Dahl, Lisa ; Vranken, Marjolein J. M. ; Jünger, Saskia et al. / Identification of challenges to the availability and accessibility of opioids in twelve European countries : conclusions from two ATOME six-country workshops. In: Journal of Palliative Medicine. 2015 ; Vol. 18, No. 12. pp. 1033-1039.

Bibtex

@article{6ac20bfd9da94ef680eac0c26e3c4bf6,
title = "Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops",
abstract = "Background: Access to many controlled medicines is inadequate in a number of European countries. This leads to deficits in the treatment of moderate to severe pain as well as in opioid agonist therapy.Objective: The study objective was to elaborate the reasons for this inadequacy. The work plan of the Access to Opioid Medication in Europe (ATOME) project included two six-country workshops. These workshops comprised a national situational analysis, drafting tailor-made recommendations for improvement and developing action plans for their implementation.Methods: In total, 84 representatives of the national Ministries of Health, national controlled substances authorities, experts representing regulatory and law enforcement authorities, leading health care professionals, and patient representatives from 13 European countries participated in either one of the workshops. The delegates used breakout sessions to identify key common challenges. Content analysis was used for the evaluation of protocols and field notes.Results: A number of challenges to opioid accessibility in the countries was identified in the domains of knowledge and educational, regulatory, legislative, as well as public awareness and training barriers that limit opioid prescription. In addition, short validity of prescriptions and bureaucratic practices resulting in overregulation impeded availablity of some essential medicines. Stigmatization and criminalisation of people who use drugs remained the major impediment to increasing opioid agonist program coverage.Conclusions: The challenges identified during outcomes of the workshops were used as the basis for subsequent dissemination and implementation activities in the ATOME project, and in some countries the workshop proceedings already served as a stepping-stone for the first changes in regulations and legislation.",
author = "Lisa Linge-Dahl and Vranken, {Marjolein J. M.} and Saskia J{\"u}nger and Kate North and Willem Scholten and Payne, {Sheila Alison} and Lukas Radbruch",
note = "Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/jpm.2015.0051",
year = "2015",
month = dec,
doi = "10.1089/jpm.2015.0051",
language = "English",
volume = "18",
pages = "1033--1039",
journal = "Journal of Palliative Medicine",
issn = "1096-6218",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

RIS

TY - JOUR

T1 - Identification of challenges to the availability and accessibility of opioids in twelve European countries

T2 - conclusions from two ATOME six-country workshops

AU - Linge-Dahl, Lisa

AU - Vranken, Marjolein J. M.

AU - Jünger, Saskia

AU - North, Kate

AU - Scholten, Willem

AU - Payne, Sheila Alison

AU - Radbruch, Lukas

N1 - Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/jpm.2015.0051

PY - 2015/12

Y1 - 2015/12

N2 - Background: Access to many controlled medicines is inadequate in a number of European countries. This leads to deficits in the treatment of moderate to severe pain as well as in opioid agonist therapy.Objective: The study objective was to elaborate the reasons for this inadequacy. The work plan of the Access to Opioid Medication in Europe (ATOME) project included two six-country workshops. These workshops comprised a national situational analysis, drafting tailor-made recommendations for improvement and developing action plans for their implementation.Methods: In total, 84 representatives of the national Ministries of Health, national controlled substances authorities, experts representing regulatory and law enforcement authorities, leading health care professionals, and patient representatives from 13 European countries participated in either one of the workshops. The delegates used breakout sessions to identify key common challenges. Content analysis was used for the evaluation of protocols and field notes.Results: A number of challenges to opioid accessibility in the countries was identified in the domains of knowledge and educational, regulatory, legislative, as well as public awareness and training barriers that limit opioid prescription. In addition, short validity of prescriptions and bureaucratic practices resulting in overregulation impeded availablity of some essential medicines. Stigmatization and criminalisation of people who use drugs remained the major impediment to increasing opioid agonist program coverage.Conclusions: The challenges identified during outcomes of the workshops were used as the basis for subsequent dissemination and implementation activities in the ATOME project, and in some countries the workshop proceedings already served as a stepping-stone for the first changes in regulations and legislation.

AB - Background: Access to many controlled medicines is inadequate in a number of European countries. This leads to deficits in the treatment of moderate to severe pain as well as in opioid agonist therapy.Objective: The study objective was to elaborate the reasons for this inadequacy. The work plan of the Access to Opioid Medication in Europe (ATOME) project included two six-country workshops. These workshops comprised a national situational analysis, drafting tailor-made recommendations for improvement and developing action plans for their implementation.Methods: In total, 84 representatives of the national Ministries of Health, national controlled substances authorities, experts representing regulatory and law enforcement authorities, leading health care professionals, and patient representatives from 13 European countries participated in either one of the workshops. The delegates used breakout sessions to identify key common challenges. Content analysis was used for the evaluation of protocols and field notes.Results: A number of challenges to opioid accessibility in the countries was identified in the domains of knowledge and educational, regulatory, legislative, as well as public awareness and training barriers that limit opioid prescription. In addition, short validity of prescriptions and bureaucratic practices resulting in overregulation impeded availablity of some essential medicines. Stigmatization and criminalisation of people who use drugs remained the major impediment to increasing opioid agonist program coverage.Conclusions: The challenges identified during outcomes of the workshops were used as the basis for subsequent dissemination and implementation activities in the ATOME project, and in some countries the workshop proceedings already served as a stepping-stone for the first changes in regulations and legislation.

U2 - 10.1089/jpm.2015.0051

DO - 10.1089/jpm.2015.0051

M3 - Journal article

VL - 18

SP - 1033

EP - 1039

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

SN - 1096-6218

IS - 12

ER -